Benzinga | Nov 12, 2021 07:31AM EST

CASI Pharmaceuticals Q3 EPS $(0.07) Misses $(0.05) Estimate, Sales $8.11M Beat $7.54M Estimate

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 50 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $8.11 million which beat the analyst consensus estimate of $7.54 million by 7.59 percent. This is a 91.23 percent increase over sales of $4.24 million the same period last year.